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ABSTRACT: In vitro cell culture systems are an invaluable
tool for cell biological research to study molecular pathways
and to characterize processes critical in human pathophysi-
ology. However, the experimental conditions in two-dimen-
sional (2D) cell cultures often diﬀer substantially from the in
vivo situation, which continuously raises concerns about the
reliability and conferrability of the obtained results. Three-
dimensional (3D) cell cultures have been shown to closer
mimic in vivo conditions and are commonly employed, for
example, in pharmacological screens. Here, we introduce a 3D
cell culture system based on a mixture of collagen I and matrigel amenable to stable isotope labeling by amino acids in cell
culture (SILAC) and quantitative mass spectrometry-based proteomics analyses. We study the extra- and intracellular proteomic
response of skin ﬁbroblast isolated from healthy volunteers in comparison to cancer-associated ﬁbroblasts (CAF) on 3D culture
conditions. Both, control cells and CAF, change their proteomic composition based on the culture conditions. Critically, cell
type diﬀerences observed in 2D are often not preserved in 3D, which commonly closer resemble phenotypes observed in vivo.
Especially, extracellular matrix and plasma membrane proteins are diﬀerentially regulated in 2D versus 3D.
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■ INTRODUCTION
Biomedical science proﬁted enormously from the introduction
of in vitro tissue cultures, which allow routine analysis and
perturbation of cell biological processes. Commonly, mamma-
lian cells are kept in two-dimensional (2D) cultures using
coated tissue ﬂasks or dishes made of plastic. Although 2D cell
cultures have well proven their usefulness, purists still claim
that “cells grown on plastic” do not allow substantial insights
into in vivo processes and pathways, advocating the use of
diverse model organisms. Especially, new drug candidates still
have to be tested extensively in preclinical animal models.
However, animal models also present diverse pitfalls. It is now
widely recognized that due to interspecies variations, animal
models often do not recapitulate all aspects of human diseases,
hampering successful drug development.1 One in vitro
technique that can bridge the wide gap between human 2D
cell cultures and animal models and also address distinctions of
species is three-dimensional (3D) human cell culture.
Especially in drug development and testing, 3D cell culture
models hold great promise.1
In cancer research, several studies showed that 3D human
cell cultures closer mimic the in vivo situation compared to 2D
cultures.2−4 This could be especially true for the study of the
role of the tumor stroma, that is, the role of cancer-associated
ﬁbroblasts (CAF), the major stromal cell type, involved in
tumor progression.5 CAF were shown to remodel the protein
composition of the extracellular matrix (ECM) as well as its
physicochemical properties.6,7 CAF are stimulated by inﬂam-
matory conditions often observed in solid tumors and
represent activated ﬁbroblasts having similarities with wound-
associated ﬁbroblasts.8,9 Critically, CAF were shown to
promote tumor growth by secretion of growth factors and
hormones10 and to promote cancer cell invasion by ECM
deformation, generating tracks that can guide migration of
cancer cells.7 A global analysis on how CAF alter the ECM is
still missing, and it is not well understood how and which
ECM proteins stimulate cancer cell growth and migration. To
address these fundamental questions, we aimed to develop a
quantitative mass spectrometry (MS)-based proteomics
protocol that allows the identiﬁcation and accurate quantiﬁ-
cation of CAF proteins and of their microenvironment.
To study the cellular response to 3D culture conditions by
proteomics approaches, mainly 3D spheroid cultures or 3D cell
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layers were used.11−13 So far, stable isotope labeling by amino
acids in cell culture (SILAC)-based quantitative MS analyses14
of 3D cell cultures were performed of endothelial cells grown
in matrigel using a SILAC labeled 2D spike-in15 or of SILAC-
labeled embryonic stem cells.16 Recently, a SILAC protocol for
organoids was published obtaining 85% label incorporation
after 30 days in culture.17 Critically, to our knowledge, all
published studies puriﬁed cells/organoids prior MS analyses
and focused on the characterization of intracellular proteomes.
The protein compositions of the microenvironments were not
studied. However, because of the speciﬁc role CAF play in
cancer cell invasion, our aim was to establish an approach
addressing both the intracellular and extracellular compart-
ments. Thus, we developed a SILAC-based protocol, allowing
the complete labeling of ﬁbroblasts grown in a 3D matrix
consisting of a mixture of collagen I and matrigel. Such cultures
are commonly used in cell biological assays to study the
capacity of ﬁbroblasts to deform ECM,7,18 a proxy to study the
promotion of cancer cell invasion by stromal cells. In the
current study, we focused on the technical aspects of 3D cell
cultures without addressing the heterogeneity of primary
human cell types. We performed comparative expression
proteomics experiments of CAF and normal human skin
ﬁbroblasts (NHF) isolated from healthy volunteers and
analyzed cell type-speciﬁc responses to 3D culture conditions.
■ EXPERIMENTAL SECTION
Cells
NHF were isolated from the foreskin of a circumcised 4 year-
old healthy boy as described previously.19 CAF were isolated
from a head and neck squamous cell carcinoma as published.7
The study was approved by the Ethics Committee of Freiburg
University and conducted according to the Declaration of
Helsinki.
Stable Isotope Labeling by Amino Acids and 3D Cell
Culture
For the establishment of 3D cultures, NHF and CAF were
cultured and passaged in SILAC-Dulbecco’s modiﬁed Eagle’s
medium (Thermo Fisher Scientiﬁc), supplemented with 10%
dialyzed fetal bovine serum (Gibco), 1% penicillin/streptomy-
cin (Invitrogen), 1% L-glutamine (PAN Biotech), 84 mg L−1 L-
arginine (Sigma-Aldrich), 146 mg L−1 L-lysine (Sigma-
Aldrich), and 125 mg L−1 proline (Sigma-Aldrich) for 10
days, followed by 1 week in serum-free medium. Insulin (10
mg L−1)−transferrin (5.5 mg L−1)−selenium (0.0067 mg L−1)
supplement (Gibco) was used as a serum substitution. In
addition, ﬁbroblasts were treated with 50 μg mL−1 ascorbate
for proper collagen production.20 Finally, 5 × 105 ﬁbroblasts
were embedded in 1 mL of collagen I (4.6 mg mL−1)−matrigel
(2.2 mg mL−1)7 containing 5× SILAC DMEM and cultured
for up to 5 days under serum-free conditions in the presence of
insulin−transferrin−selenium and ascorbate. The 5× SILAC
DMEM was made with powdered DMEM (Thermo Fisher
Scientiﬁc) and 420 mg L−1 L-arginine, 730 mg L−1 L-lysine, and
625 mg L−1 proline. For the preparation of the collagen I−
matrigel matrix, 5× DMEM was diluted 1:10. Thus, the ﬁnal
concentration in the gel was 42 mg L−1 L-arginine, 73 mg L−1
heavy L-lysine, and 62.5 mg L−1 proline. Every other day,
medium was replaced by fresh regular SILAC medium (see
above).
For 2D culture, 10 cm culture plates were coated with 5 mL
of 20 μg mL−1 collagen I (Corning) and 27 μg mL−1 matrigel
(growth factor-reduced, Corning) in 0.02 M acetic acid for 1 h
at 37 °C and 5% CO2. Primary ﬁbroblasts for the super-SILAC
mix were grown in 2D and labeled with 42 mg L−1 L-arginine,
73 mg L−1 L-lysine (Sigma-Aldrich), and 80 mg L−1 proline.
“Heavy” L-arginine-13C6-
15N4 (Arg10) and L-lysine-
13C6-
15N2
(Lys8) or “medium-heavy” L-arginine-13C6 (Arg6) and L-
lysine-2H4 (Lys4) amino acids were used. The “light” label was
not used. Biological replicates were obtained by swapping
labels.
Protein Solubilization and MS Sample Preparation
Cells were lysed after 5 days of 2D or 3D culture in 1 mL of 2×
RIPA buﬀer.21 Pellet and supernatant were separately
processed for in-gel digestion. Samples were concentrated on
a 10 kDa cutoﬀ ﬁlter (Sartorius) and supplemented with SDS−
PAGE loading buﬀer. Disulﬁde bonds were reduced with 1
mM DTT (Sigma-Aldrich) for 5 min at 95 °C and alkylated
using 5.5 mM iodoacetamide (Sigma-Aldrich) for 30 min at 25
°C. The mixing ratio was determined by setup experiments:
aliquots were mixed, proteins digested, and peptides quantiﬁed
by MS. Samples were mixed in a 1:1 peptide ratio. Protein
mixtures were separated by SDS−PAGE using 4−12% Bis-Tris
gradient gels (Invitrogen). Gel lanes were cut into 10 slices,
proteins therein were digested with trypsin (Promega), and
peptides were processed on STAGE tips as described.19
Mass Spectrometry
MS analyses were conducted on an LTQ Orbitrap XL and 3D
cultures were also analyzed on a QExactive Plus mass
spectrometer (both Thermo Fisher Scientiﬁc). For the LTQ
Orbitrap XL, samples were separated by an Agilent 1200
HPLC, for the QExactive an EasyLC 1000 (Thermo Fisher
Scientiﬁc) was coupled to the mass spectrometer. Chromatog-
raphy was conducted with in-house packed Reprosil−Pur 120
ODS−3 (Dr. Maisch) fused silica HPLC−columns with 75 μm
inner diameter. Samples were applied to the column with a
gradient of A (0.5% acetic acid) and B (0.5% acetic acid in 80%
ACN) with increasing ACN proportion for peptide separation.
Samples were loaded with 2% B; a separation gradient was run
for 100 min increasing the percentage of buﬀer B to 35%. The
spray voltage was 2.3 kV with no sheath and auxiliary gas ﬂow
and an ion-transfer tube temperature of 200 °C (250 °C for
the QExactive). The data were acquired in the data-dependent
mode and switched automatically between MS and MS/MS
with a maximum of 1 × 106 ions in MS. The top ﬁve (top 10
for the QExactive) most abundant peptides were isolated in
the linear ion trap and fragmented with 35% collision energy
(25% for the QExactive) and a target value of 5000. Parent
ions with a charge state of z = 1 and unassigned charge states
were excluded from fragmentation. The mass range for the
LTQ Orbitrap was set to 350−2000 m/z with a resolution of
60 000, for the QExactive Plus the mass range was 370−1750
m/z with a resolution of 70 000.
Identiﬁcation and Quantiﬁcation of Proteins Using
MaxQuant
Raw mass spectra data ﬁles were searched with the MaxQuant
software version 1.4.1.222 using a UniProt Homo sapiens
database from March 2016, containing 21 033 entries. The
deﬁned ﬁxed modiﬁcation was carbamidomethylation of
cysteines, whereas methionine oxidations and protein amino-
terminal acetylations were set as variable modiﬁcations. Three
missed cleavages were allowed for enzymatic cleavage with
trypsin/P. Quantitation was done with a setting of double or
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triple SILAC. The MS/MS tolerance was set to 0.5 Da,
whereas the average mass precision of identiﬁed peptides was
less than 20 ppm. FDRs of 0.01 were applied for peptide and
protein identiﬁcation, the minimum peptide length was set to
seven, and at least one peptide was unique. For quantiﬁcation,
a minimum ratio count of two was chosen. Identiﬁed proteins
were requantiﬁed.
MS proteomics data were deposited to the ProteomeX-
change Consortium via the PRIDE23 partner repository with
the data set identiﬁer PXD009424.
qRT-PCR
RNA was isolated with an RNA isolation kit (Quiagen) or by
Tri-Reagent (Sigma) homogenization, chloroform extraction,
and isopropyl alcohol precipitation. Extracted RNA was further
puriﬁed with an RNeasy cleanup kit (Quiagen). One
microgram of RNA was used for reverse transcription with a
Quantitect RT kit (Qiagen) and the gDNA wipeout reaction
to eliminate genomic DNA was performed for 10 min at 42 °C.
Primers were mixed equally at 50 μM. qRT-PCR was
performed with a Rotor-Gene Q (Quiagen). The KAPA
SYBR Fast qPCR mix (KAPA Biosystems) was used for the
PCR according to the manufacturer’s recommendations.
Double strands were separated by heating to 95 °C for 10
min; then 40 cycles were performed of 10 s at 95 °C, 15 s 60
°C, and 20 s 72 °C. Primer sequences were as follows: for
TGM2, forward 5′-CCA ACT ACA ACT CGG CCC AT-3′,
reverse 5′-CTG GTC ATC CAC GAC TCC AC-3′; for TNC,
Figure 1. Quantitative proteome comparison of CAF and NHF grown in 2D. (A) SILAC labeling strategy of cells from 2D cultures. Cells were
SILAC labeled for 10 days in DMEM supplemented with 10% dialyzed (d)FBS. At day 10, cells were deprived of dFBS and DMEM supplemented
with ascorbate and insulin−transferrin−selenium was used for 7 days. Subsequently, cells were transferred to collagen I−matrigel coated dishes for
5 days. After lysis, cells were mixed with a super-SILAC mix and submitted to in-gel digestion. (B) Protein abundance plot comparing CAF and
NHF proteomes by a SILAC approach (n = 2). Signiﬁcantly altered proteins were determined by performing outlier tests using Signiﬁcance B
values generated by MaxQuant22 and Perseus.24 Regulated proteins are highlighted in blue (p ≤ 0.05) and in red (p ≤ 0.01), respectively. (C)
STRING network analysis of signiﬁcantly regulated proteins in CAF and NHF (p ≤ 0.01). (D) GO-term enrichment analysis (p ≤ 0.03, colored
circles) of signiﬁcantly regulated proteins.
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forward 5′-ACA GGC GAG AAA GTG CCA GA-3′, reverse
5′-TGT GTA TTC CGT GGC AGG CT-3′; for MYOF,
forward 5′-TCA GAA CGA GAG CCG CTA CC-3′, reverse
5′-TTA TCG CCG TTC GCA TCC GT-3′. Data were
normalized to HPRT, which was used as internal control with
the following primers: forward 5′-TGA CAC TGG CAA AAC
AAT GCA-3′, reverse 5′-GGT CCT TTT CAC CAG CAA
GCT-3′.
Western Blot
Three-dimensional gels were dissolved in 2× RIPA buﬀer
supplemented with phosphatase and protease inhibitors
(Roche). Lysates were dissolved with a syringe and DNA
was digested with 0.1% v/v benzonase (Emprove Bio).
Samples were centrifuged for 12 min at 13 500 rpm at 4 °C.
The volume of the supernatant was reduced on a 10 kDa cutoﬀ
ﬁlter (Sartorius) and supplemented with SDS-PAGE loading
buﬀer. Proteins were separated by SDS-PAGE and blotted
onto nitrocellulose membranes. The membranes were blocked
for 30 min in 5% BSA in 1× TBS with 0.1% Tween-20.
Primary antibodies were anti-GAPDH, HRP (sc-25778HRP),
and anti-MYOF (sc-376879), both Santa Cruz Biotechnology.
Antibodies were diluted 1:1000 in TBS-0.1% Tween with 5%
BSA and incubated with the membranes overnight at 4 °C.
The HRP-conjugated sheep anti-mouse secondary antibody
(GE Healthcare) was diluted 1:10 000 in 5% BSA in TBS-0.1%
Tween and incubated with the membrane for 1 h at room
temperature. Chemiluminescence was detected by SuperSignal
West Femto Maximum Sensitivity Substrate (Thermo
Scientiﬁc).
Data Analyses
Data analysis was performed using Perseus.24 Signiﬁcantly
regulated proteins were identiﬁed by performing outlier tests
relative to the respective log2-transformed total data set
(Signiﬁcance A, p < 0.05). To determine intensity-dependent
outliers, Signiﬁcance B (p < 0.05) was used.22 Generation of
protein networks was done in STRING DB.25 Network
analysis and GO-term statistics were done with Cytoscape
3.5.126 and BINGO 3.0.3.27 Calculation of ontology enrich-
ment was conducted on the background of the entire data set.
Ontology nodes with a p-value ≤ 0.03 were determined as
signiﬁcant. For the 2D data set, proteins with a p-value ≤ 0.01
were evaluated on the background of 1117 proteins. For 3D,
proteins with a p-value ≤ 0.05 were analyzed on the
background of 961 proteins.
■ RESULTS AND DISCUSSION
NHF and CAF Grown in 2D Diﬀer in Their Proteomes
As CAF were characterized to promote tumor cell invasion
compared to NHF,7,28 we asked if these phenotypic diﬀerences
were reﬂected by proteome alterations under standard 2D cell
culture conditions. Using a super-SILAC approach the
proteomes of NHF and CAF cultured in 2D on coated dishes
were analyzed quantitatively by geLC−MS/MS (Figure 1A;
see Experimental Section for details).29 Serum leads to
ﬁbroblast activation triggering wound repair responses30 and
promoting expression of genes commonly expressed in
tumors.9 Thus, to be able to discriminate ﬁbroblasts activated
in vivo, that is, CAF, from nonactivated ﬁbroblasts, we
implemented a serum-free cell culture strategy.
We identiﬁed 2577 proteins of which 1147 could be
quantiﬁed in at least one replicate each using an LTQ-Orbitrap
XL (n = 2, Supplementary Figure S1, Supplementary Table
S1). Out of the 1147 common proteins, 142 proteins were
signiﬁcantly diﬀerentially regulated between NHF and CAF
(Figure 1B; p ≤ 0.05). 74 proteins showed a signiﬁcantly
higher protein abundance in NHF than in CAF, whereas 68
proteins were enriched in CAF. Interestingly, 74 of the
diﬀerentially regulated proteins are known to interact
according to STRING DB (Figure 1C).31 We performed
GO-term enrichment analyses to identify cellular pathways/
processes, which might be aﬀected by the altered proteome
composition in CAF. Proteins involved in adherens junction (p
= 0.007), cell−cell adhesion (p = 0.01), wound healing (p =
0.003), nucleotide metabolic processes (p = 0.007), and
proteins localizing to the cell surface (p = 0.02) were
signiﬁcantly diﬀerentially regulated (Figure 1D and Supple-
mentary Figure S2), corroborating the ﬁnding that CAF are a
terminally modiﬁed cell type that can be propagated in vitro.
Among others, we identiﬁed an upregulation of catenin beta-1
(CTNNB1), which was shown to be critical for CAF to guide
collective cell migration.32 CTNNB1 is a key component of the
canonical Wnt signaling pathway, which was linked to the pro-
invasive phenotype of CAF.33
Although we detected signiﬁcant diﬀerences between CAF
and NHF that could be linked to the tumor-promoting
phenotype of CAF observed in vivo, we were wondering if we
missed important information due to the limitations of our cell
culture model. Therefore, we decided to establish a cell culture
system that highlights in vivo relevant, phenotypic diﬀerences
between CAF and NHF and, importantly, that allows the
quantitative comparison of CAF and NHF proteomes.
Contraction of 3D Cell Cultures Is a Readout for Tumor
Invasion-Promoting Eﬀects of Stromal Cells
Fibroblasts can be propagated in 3D cultures based on a
mixture of collagen I and matrigel. Critically, activated
ﬁbroblasts remodel and contract the gel34 and the extent of
contraction was shown to correlate with the ability of
ﬁbroblasts to promote tumor cell invasion.35,36 To not conceal
phenotypic diﬀerences between CAF and NHF, ﬁbroblast
subtypes were again kept serum-free. As expected, intrinsically
activated CAF contracted the matrix signiﬁcantly stronger and
faster than NHF (Figure 2). After 1 day, CAF showed an
average matrix contraction by 26%, whereas NHF contracted
the gel only by 10% (p < 0.001). After 5 days, CAFs reduced
the gels by 42% of its original size and NHF by 26% (p <
0.01). To identify the diﬀerentially regulated molecular
mechanisms in CAF grown in such a collagen I and
matrigel-based 3D culture, we adapted the culture conditions
Figure 2. CAF contract 3D matrices stronger than NHF. (A) Pictures
of NHF and CAF grown in 3D culture show the activated phenotype
of CAF by (B) signiﬁcantly enhanced gel contraction (NHF n = 6,
CAF n = 8, two-tailed, homoscedastic t -test). ∗∗∗p ≤ 0.001, ∗∗p ≤
0.01, ∗p ≤ 0.05.
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and established a SILAC-based quantitative proteomics
approach addressing both the cellular proteome of ﬁbroblasts
and the ECM embedding the cells grown in 3D.
3D-SILAC for Quantitative MS Analyses
As collagen I is isolated from rat-tails and matrigel from
Engelbreth-Holm-Swarm mouse sarcoma cells, both products
contain unlabeled proteins that may get reused by cells. In
addition, both products may contain free, unlabeled amino
acids, which would negatively interfere with SILAC labeling.
Hence, we established a SILAC protocol based on powdered
DMEM to be able to modify medium compositions at will (see
Experimental Section for details). However, before analyzing
label incorporation using our new setup, we comprehensively
mapped the matrigel and collagen I solution proteomes to
identify all proteins that potentially share peptides between
mouse/rat and human orthologues and to be able to exclude
these proteins for the determination of labeling eﬃciency. We
detected 435 murine proteins in matrigel of which laminin
subunit beta-1 and gamma-1, nidogen-1, vimentin, and
ﬁbrinogen gamma chain showed the highest intensities in
agreement to published data.16 176 of these share common
peptides with human orthologues. The puriﬁed collagen I
solution contained 56 diﬀerent rat proteins with the highest
intensities for collagen alpha-1 and alpha-2 chains, vimentin
and actin, and all of these share peptides with human
orthologues (Supplementary Table S2). For the determination
of metabolic labeling eﬃciencies, we excluded respective
proteins.
Using an analogous cell culture protocol as for 2D, we
performed 3D-SILAC-based quantitative proteomics analyses.
After 10 days in full SILAC medium and an additional 7 days
in serum-deprived medium in 2D culture, ﬁbroblasts were
transferred for 5 days to serum-deprived 3D cultures (Figure
3A). Incubation with 42 mg L−1 heavy L-arginine and 73 mg
L−1 heavy L-lysine showed a median labeling eﬃciency of
90.3% and 93.7%, respectively (Supplementary Figure S3). To
optimize label incorporation, we cultured ﬁbroblasts in DMEM
containing 84 mg L−1 heavy L-arginine, 146 mg L−1 heavy L-
lysine, and 125 mg L−1 proline to counteract arginine-to-
proline conversion. We reached 95.8% labeling eﬃcacy of
lysine- and 96.5% of arginine-containing peptides (Figure 3B),
which is similar to results obtained in 2D.37 Arginine-to-proline
conversion was below 4% (Supplementary Figure S3). Thus,
this 3D-SILAC approach permits an accurate quantitative
analysis of diﬀerent cell types and their produced ECM grown
in 3D cultures as well as a characterization of the inﬂuence of
culture conditions on cellular proteomes.
Cells Grown in 3D Upregulate Proteins Involved in ECM
Organization and Establishment of Cell−ECM Contacts
First, we asked which pathways were aﬀected by 3D culture
conditions independently of the used cell type and
quantitatively compared the proteomes of CAF and NHF
grown in 3D to respective cells grown in 2D cultures (Figure
4A). SILAC-labeled cells grown for 5 days in 3D or in 2D,
respectively, were mixed in a 1:1 peptide ratio and analyzed by
LC−MS/MS. To be able to discriminate cellular peptides from
3D matrix peptides, cells were exclusively labeled by “medium-
heavy” and “heavy” amino acids, whereas the “light” label was
used to identify nonlabeled matrigel and collagen I peptides,
which were excluded from further analysis (Figure 4A). We
identiﬁed 1515 proteins of which we could quantify 1107
proteins in two replicates each (Supplementary Figure S4 and
Supplementary Table S3). Interestingly, comparison of the two
culture conditions showed a signiﬁcant upregulation of protein
populations in 3D cultures (Figure 4B; Signiﬁcance A, p <
0.05). According to a GO analysis, 3D cell cultures stimulate
the expression of proteins involved in ECM organization (FDR
Figure 3. 3D-SILAC setup. (A) SILAC labeling strategy for primary
human ﬁbroblasts grown in 3D culture. Fibroblasts were SILAC
labeled for 10 days in full medium and further incubated for 7 days in
serum-deprived medium in 2D. After 5 days in 3D, cells were lysed
and processed by geLC-MS/MS. (B) Isotopic label incorporation of
CAF. The 1275 lysine- and 1130 arginine-containing peptides were
analyzed for their incorporation eﬃciency (Arg10, Lys8) in relation to
unlabeled peptides (Arg0, Lys0). The dotted lines mark the median
labeling eﬃciencies.
Figure 4. Comparison of 2D and 3D culture conditions. (A)
Experimental workﬂow and data processing. MaxQuant database
searches were performed using “triple SILAC” as quantiﬁcation mode.
Light SILAC-labeled proteins were excluded from further analysis.
(B) Histogram of 3D versus 2D protein ratios of NHF (left) and CAF
(right). Enlarged are log2 SILAC ratios smaller than −1.3 and greater
than 1.3. 3D culture conditions led to an upregulation of protein
subsets. (C) GO-term enrichment analysis (FDR < 0.05, BH
corrected) for signiﬁcantly up- and downregulated proteins in CAF,
NHF, or in both is shown (signiﬁcance A, p < 0.05, BH-corrected). A
STRING DB analysis of the 36 commonly regulated proteins
identiﬁed proteins known to potentially interact.
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= 4.8 × 10−11) and collagen ﬁbril organization (FDR = 8.62 ×
10−5) irrespectively of the used cell type (Figure 4C). Among
these ECM proteins, we identiﬁed several proteins that were
previously shown to be involved in tumor progression. The
proteoglycan biglycan (BGN) was found upregulated in CAF
by increased TGF-β1 and bFGF signaling38 and was shown to
promote melanoma invasion.39 Also, the heparin-binding
protein periostin (POSTN) was shown to be induced by
bFGF signaling and to promote cancer cell survival.40
Taken together, 3D culture conditions signiﬁcantly altered
the protein compositions of cells and led to an upregulation of
cellular proteins critical for the establishment and maintenance
of ECM−cell contacts. Critically, 3D culture conditions might
reveal diﬀerentially regulated proteins important in disease,
which are not as such detectable or regulated under 2D culture
conditions. To characterize potential CAF-speciﬁc mechanisms
critical for ECM contraction, we performed a diﬀerential
analysis comparing NHF and CAF proteomes of cells grown in
3D.
3D Culture Conditions Induce CAF-Speciﬁc Changes That
Are Not Observable in 2D
Using our 3D-SILAC approach, we directly compared NHF
and CAF grown in 3D by normalizing them to a common
super-SILAC mix as described in Figure 1A. We identiﬁed
2′238 proteins of which we could quantify 979 in two
replicates each (Figure 5A, Supplementary Figure S5,
Supplementary Table S4). In total, 94 proteins were
signiﬁcantly altered between NHF and CAF (p ≤ 0.05), of
which 64 potentially interact according to STRING DB.
Importantly, the network contained a cluster of diﬀerentially
regulated ECM proteins, proteins associated with extracellular
space and regulation of extracellular stimuli (Figure 5B, center
circle). GO analysis of signiﬁcantly regulated proteins showed
an enrichment for proteins involved in vacuolar and lysosomal
transport (p = 0.008), regulation of response to stress (p =
0.009), multicellular organismal process (p = 0.0047), and
cellular development and diﬀerentiation (p = 0.02; Figure 5C,
Supplementary Figure S6). Especially the latter two terms
nicely reﬂect the inﬂuence of 3D culture conditions. By
comparing our data sets with a published ex vivo analysis of
breast cancer biopsies, it became evident that the 3D data set
Figure 5. Comparison of proteomes of CAF and NHF gown in 3D. (A) Protein abundance plot comparing 3D-CAF and -NHF proteomes by a
SILAC approach (n = 2). Signiﬁcantly altered proteins were determined by performing outlier tests using Signiﬁcance B values generated by
MaxQuant22 and Perseus.24 Regulated proteins are highlighted in blue (p ≤ 0.05) and in red (p ≤ 0.01), respectively. (B) STRING network
analysis of signiﬁcantly regulated proteins of CAF and NHF in 3D culture (p < 0.05). (C) GO-term enrichment (p ≤ 0.03, colored circles) of
signiﬁcantly regulated proteins in 3D culture in CAF in comparison to NHF.
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correlated slightly better compared to the 2D data set (Pearson
coeﬃcient of 0.38 versus 0.32 (Supplementary Figure S7).41
Also, in 3D cultures, published CAF biomarkers better
resembled in vivo observations.42 Out of 113 CAF marker
proteins, we identiﬁed 16 in 3D and 17 in 2D, respectively.
Critically, in 3D, 15 out of 16 proteins were regulated as
published, whereas in 2D, only 7 out of 17 were regulated
consistently (Supplementary Table S5). Thus, compared to 2D
cultures, 3D culture systems appear to mimic closer
observations made in vivo.
Interestingly, by comparing single proteins that were
identiﬁed as signiﬁcantly regulated in 3D or in 2D, it became
evident that only few proteins overlapped (Figure 6A,
Supplementary Table S6). More importantly, some proteins
were opposingly regulated: four proteins were signiﬁcantly
upregulated in CAF in 3D, but in 2D they were upregulated in
NHF. Among these proteins was TRIM28, a transcription
factor known to be higher expressed in cancerous tissues43 and
transgelin (TAGLN), an actin cross-linking protein, which
mediates cell contractility and promotes migration and
invasion of cancer stem cells.44 In 3D, caveolin-1 (CAV-1)
was decreased in CAF in comparison to NHF, whereas in 2D,
CAV-1 was higher expressed in CAF than in NHF. Decreased
CAV-1 expression in CAF is known to promote cancer cell
invasion and staining of breast cancer sections showed a clear
decrease of CAV-1 in α−SMA positive cells.45
Myoferlin (MYOF) is a protein that we found signiﬁcantly
upregulated in 3D NHF in comparison to CAF by SILAC-
based MS (p = 0.004) as well as by Western blot, with no
signiﬁcant regulation in 2D (Figure 6B,C). MYOF is a Ca2+
regulated vesicular protein known to regulate intracellular
traﬃcking of growth factor receptors.46,47 It was shown to be
overexpressed in human breast cancers regulating growth
factor receptor activation. Our results indicate that cancer cells
themselves and not the tumor stroma overexpress MYOF
implicating that MYOF plays distinct roles in cancer and
stromal cells. Interestingly, MYOF was shown to be proteolyti-
cally cleaved in breast cancer and cell lines leading to increased
ERK1/2 phosphorylation.48 We also observed diﬀerent MYOF
isoforms under 3D conditions by Western blot (Figure 6C).
Their roles in ﬁbroblasts and tumor stroma will have to be
addressed in future studies.
Two proteins that are known to be important for CAF
biology are tenascin (TNC) and transglutaminase 2 (TGM2)
(Figure 6D,E). TNC, an ECM glycoprotein upregulated in
wound healing and cancer which also inﬂuences gene
expression,49 was highly upregulated under 3D culture
conditions in CAF (p = 1.8 × 10−8).50,51 In 2D conditions,
this diﬀerence was not observed. Interestingly, upregulation of
TNC appeared to be regulated on gene expression level as
indicated by increased mRNA levels (Figure 6F). In contrast,
abundance of transglutaminase 2 (TGM2) was signiﬁcantly
elevated in NHF in comparison to CAF in 3D (p = 0.01). In
2D, no signiﬁcant diﬀerences in TGM2 abundance could be
observed, but CAF showed tendencies of higher TGM2 levels
than NHF. TGM2 is among others critical for cross-linking of
ECM proteins and ECM stability.52 Its roles in cancer are
controversially discussed as it might have pro- and
Figure 6. Diﬀerential abundances of proteins in 2D and 3D cultures. (A) Venn diagram of proteins that were identiﬁed as signiﬁcantly regulated
comparing proteomes of CAF and NHF in 2D or 3D (Signiﬁcance B, p < 0.05). (B) Normalized fold change of SILAC ratios of MYOF of cells
grown in 2D and 3D, normalized to 3D NHF1. Error bars indicate variability of respective peptide quantiﬁcations. Signiﬁcance B was calculated
with p < 0.05 for the log2 ratios 2D CAF/2D NHF and the sum of all intensities in 2D, and with the log2 ratios of 3D CAF/3D NHF and the sum
of all intensities in 3D. (C) Western blot of MYOF in 2D and 3D NHF and CAF. Quantiﬁcation of the Western blot is shown in the lower panel (n
= 2). Normalized fold change of SILAC ratios of (D) TGM2 and (E) TNC of cells grown in 2D and 3D, normalized to 3D NHF1. Error bars
indicate variability of respective peptide quantiﬁcations. Statistical analyses were performed as in panel (B). (F) Relative gene expression of MYOF,
TGM2, and TNC under 2D and 3D culture conditions normalized to HPRT. Shown are ratios of biological replicates (n = 2 with three technical
replicates each). ∗∗∗p ≤ 0.001.
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antiapoptotic properties.53 TGM2 absence in the stroma is
thought to be a favoring condition for the formation and
development of metastases, while TGM2 in tumor cells might
be required for the development of metastases.54,55 In contrast
to TNC, TGM2, andMYOF gene expression analyses could not
be used to predict protein abundance (Figure 6F). mRNA and
protein abundance anticorrelated indicating extensive post-
transcriptional/post-translational regulatory mechanism.
■ CONCLUSION
In the current publication, we introduce a 3D cell culture
method based on a mixture of collagen I and matrigel that is
amenable to SILAC labeling and that allows an accurate
quantitative analysis of intracellular proteins and the cell
microenvironment. In addition, SILAC labeling supports the
discrimination of cell-intrinsic from exogenous matrix proteins.
Because of increased sample complexity, however, SILAC
labeling might negatively inﬂuence identiﬁcation rates. To
increase identiﬁcation rates, data-dependent as well as data-
independent label-free quantiﬁcation approaches can be used
in the future.
We highlight proteomic changes of cells, which are
transferred from 2D to 3D and speciﬁcally address the
response of CAF in 3D. Critically, 3D cell cultures highlight
cell type-speciﬁc diﬀerences that are not observable in 2D and
that closely mimic in vivo observations. Thus, our approach
should alleviate the in vitro identiﬁcation and characterization
of in vivo-relevant biomarkers and new disease targets.
Together with organoid cultures, (organotypic) 3D cell culture
systems hold great promise for improved drug development,
reducing the need for animal experiments and avoiding
nonhuman species-speciﬁc eﬀects.
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